The Wall Street Journal

Genetically Engineered Babies Tech Billionaires 6779Efc8

UNILAD

Tech billionaires back scheme many worry could lead to birth of illegal 'genetically engineered' babies

New York Post

Tech billionaires back startup probing gene-edited ‘designer babies’ despite US ban: report

illuminem

Genetically engineered babies are banned. Tech titans are trying to make one anyway

Metro

Tech bosses could be godfather to new wave of genetically engineered babies

Moneycontrol

How Silicon Valley is inching toward engineered babies: The tech, the risks and the legal grey zones

The quest to create gene-edited babies gets a reboot

Unlimited Hangout

Barbara Marx Hubbard and the Malthusian-Transhumanist Riders of the Pale Horse

Substack

The Wits Guide to Transhumanism

Metaculus

A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.

A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families "avoid disease." The broader industry has received funding from Peter Thiel, Alexis Ohanian and Anne Wojcicki.

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families "avoid disease." The broader industry has received funding from Peter Thiel, Alexis Ohanian and Anne Wojcicki.

Federal law prohibits the U.S. Food and Drug Administration (FDA) from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the country.

Federal law prohibits the U.S. Food and Drug Administration (FDA) from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the country.

As the practice is banned in over 70 countries, Preventive has looked to those where embryo editing might be permitted, including the UAE. While Preventive and another startup called Orchid Focus on disease prevention, companies like Herasight and Nucleus Genomics say they're focused on other genetic traits, including intelligence and height.

As the practice is banned in over 70 countries, Preventive has looked to those where embryo editing might be permitted, including the UAE. While Preventive and another startup called Orchid Focus on disease prevention, companies like Herasight and Nucleus Genomics say they're focused on other genetic traits, including intelligence and height.

Other startups, including only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Other startups, including only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Critics, including University of California, Berkeley's Fyodor Urnov, warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

Critics, including University of California, Berkeley's Fyodor Urnov, warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

The Wall Street Journal #

UNILAD #

New York Post #4317

illuminem #

Metro #

Moneycontrol #

NPR #13066

Unlimited Hangout #

Substack #

Metaculus #

A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.</span

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families avoid genetic illness.</span

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families avoid genetic illness.

Federal law prohibits the Food and Drug Administration from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the United States.</span

Federal law prohibits the Food and Drug Administration from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the United States.

Preventive has investigated foreign jurisdictions including the United Arab Emirates where embryo editing might be permitted, as the practice is illegal in the US and banned in over 70 countries worldwide.</span

Preventive has investigated foreign jurisdictions including the United Arab Emirates where embryo editing might be permitted, as the practice is illegal in the US and banned in over 70 countries worldwide.

The only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.</span

The only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Critics including UC Berkeley's Fyodor Urnov warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.</span

Critics including UC Berkeley's Fyodor Urnov warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

SF Startup Raises $30M for Embryo Gene Editing Research

SF Startup Raises $30M for Embryo Gene Editing Research

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

SF Startup Raises $30M for Embryo Gene Editing Research

SF Startup Raises $30M for Embryo Gene Editing Research

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters